Alvotech Holdings S.A Logo

Alvotech Holdings S.A

ALVO | LU

Overview

Corporate Details

ISIN(s):
LU2458332611
LEI:
222100DCZBOWV5DZ8372
Country:
Luxembourg
Address:
9, RUE DE BITBOURG, L-1273 LUXEMBOURG
Sector:
Health Care
Industry:
Biotechnology

Description

We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do. We have a deep appreciation for the positive impact biologic medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines are revolutionizing the way we treat diseases and improve patient lives. It is our aim to broaden the availability of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars. Our commitment to the promise of biosimilars is foundational to our approach, our culture and the strong sense of purpose that inspires us to work smarter and faster towards this mission. We are driven by passion - if there is a proven biologic medicine, we believe it should be accessible to all patients in need.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-04 01:02
Regulatory News Service
Notification for the purposes of article 13 of the Luxembourg law of 11 January…
English 1.2 KB
2025-07-02 12:23
Directors' Dealings
Notification_Managers Transaction_Richard Davies
English 84.6 KB
2025-07-02 12:21
Directors' Dealings
Notification_Managers Transaction_Hjörleifur Pálsson
English 85.0 KB
2025-07-02 12:19
Directors' Dealings
Notification_Managers Transaction_Ann Merchant
English 84.6 KB
2025-07-02 12:16
Directors' Dealings
Notification_Managers Transaction_Lisa Graver
English 84.6 KB
2025-07-02 01:54
Remuneration Report
Úthlutun nýrra kauprétta og afhending áunninna hlutabréfaréttinda
Icelandic 2.5 KB
2025-07-02 01:54
Directors' Dealings
Granting of Stock Options and Vesting of Restricted Share Units
English 2.5 KB
2025-07-01 19:05
Declaration of Voting Results & Voting Rights Announcements
Notification of Own Shares - Alvotech
English 48.3 KB
2025-07-01 19:00
Declaration of Voting Results & Voting Rights Announcements
VOTING_RIGHTS_CAPITAL_TOTAL_
English 138.4 KB
2025-07-01 10:00
Regulatory News Service
Advanz Pharma semur við Alvotech um markaðssetningu í Evrópu á hliðstæðu við lí…
Icelandic 6.3 KB
2025-07-01 10:00
Regulatory News Service
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agr…
English 14.6 KB
2025-06-26 10:15
Capital/Financing Update
Lánveitendur Alvotech lækka vexti á langtímaskuldum félagsins
Icelandic 5.8 KB
2025-06-26 10:15
Capital/Financing Update
Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility
English 12.7 KB
2025-06-25 22:45
Declaration of Voting Results & Voting Rights Announcements
Niðurstaða aðalfundar Alvotech árið 2025
Icelandic 1.5 KB
2025-06-25 22:45
Declaration of Voting Results & Voting Rights Announcements
Main Results of 2025 Annual and Extraordinary General Meeting
English 1.7 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC